LAS VEGAS, April 27, 2018 — Former NFL All-Pro Kyle Turley will be featured in the upcoming CNN “Weed” series special on medical marijuana and CBD that begins airing Sunday, April 29. Turley will be endorsing the use of cannabis and hemp products as a way to escape the addiction of opioids in the fourth installment of CNN's series on marijuana, “Weed 4: Pot vs Pills.” The show, hosted by Dr. Sanjay Gupta, will debut Sunday at 8 p.m. Eastern, 5 p.m. Pacific time.
Turley says the show takes a big step toward, “exposing the truth about this plant. People deserve the truth and I'm here to fight for it because it saved my life, the lives of my football brothers and millions of others. And unlike pharmaceuticals, THC and CBD hasn't killed a soul in the history of the world.”
Earlier this week, Gupta released an open letter to U.S. Attorney General Jeff Sessions, imploring him to decriminalize marijuana. The series “Weed” has helped remove the stigmas associated with marijuana and CBD, the cannabinoid that is extracted from cannabis and hemp that research is backing up anecdotal claims with medical science.
“The reality is,” Turley says, “the worldwide health care factor that marijuana has become can't be ignored any more. We are out here on our own proving that while the government seems content to feed us things that will kill us.”
Turley is the founder of Neuro XPF, a line of CBD-only products made after isolating CBD and terpenes from hemp strains to create a broad spectrum, THC-free product line.
“We go the extra mile to extract all THC so any youth football player has the opportunity to use this for prevention and the college and pro athletes won't fail a drug test,” Turley says.
Turley uses the isolate process to withdraw THC and then keeps the whole-plant approach. “You still have the entourage effect because you have every component of the plant except THC. We all carry THC in our system and that will ignite the entourage effect.”
Turley's products are tested in Neuro XPF labs and through Shango Las Vegas and the State of Nevada. “Every batch coming through has a testing requirement and we go through state testing every three months,” Turley said.
About “Weed 4: Pot vs Pills”
The description of the fourth installment says, “Politicians promise to lead the country out of the worst drug crisis in its history, but opioid abuse continues to kill Americans in record numbers. Are our leaders ignoring a lifesaving solution? Over 115 Americans die every day from opioid overdoses, more than those killed in car accidents, from breast cancer or even guns. Nearly 2.5 million Americans struggle with opioid addiction, and though controversial, some people believe a potentially lifesaving solution may lie in medical marijuana. In the fourth installment of his groundbreaking series, CNN chief medical correspondent Dr. Sanjay Gupta takes an in-depth look at marijuana's potential as both an alternative to opioids in treating pain and in ending opioid addiction.”
About Kyle Turley
Diagnosed with chronic traumatic encephalopathy (CTE) due to the 100-plus concussions he received during the 10 years he played as an NFL offensive lineman, Kyle Turley struggled with pharmaceutical addiction, violent thoughts and suicidal tendencies — until he started taking medical marijuana. “It saved my life,” he says. “I wouldn't be where I am today, I would not have my family, my kids, my house, everything I have right now, if not for cannabis.” To help save other lives, Turley founded the Gridiron Cannabis Coalition to use his story and those of other players to advance the idea of marijuana as a valid medicine for neurological conditions and other athletic injuries. He donates proceeds from sales to Gridiron Greats founded by Mike Ditka. “CBD has the unique opportunity to address the growing crisis in our football community and, this is why I created Neuro XPF.”
About Neuro XPF
CBD (cannabidiol) has shown in studies to have neuro-protective and antioxidative properties that could address a myriad of maladies facing our military and NFL veterans while supporting the general health and wellbeing of all athletes. Knowing the value of the plant and the hurdles that the government and big pharma has placed on marijuana, Kyle Turley has created Neuro XPF, a lab-tested, federal-guideline compliant, THC-free, CBD (hemp-derived) cannabis supplement focused on Bioavailability.
“Neuro XPF uses a special CO2 extracting process to isolate the CBD, working hard to preserve the terpenes to modulate the effect of Neuro XPF,” he says. ”This adds that little extra punch to Neuro XPF products so they taste better and provide more beneficial qualities.” These products include various delivery systems and potencies based on preference and need. For more info, see www.neuroxpf.com or www.goshango.com.
Shango is a premium cannabis brand licensed to a full range of award-winning cannabis products, including flower, extracts and cannabis-infused edibles, produced by select cultivators and processors in Oregon, Nevada and Washington. The Shango brand also is licensed to six full-service recreational and medical cannabis dispensaries in Oregon and Nevada. A recognized leader in the cannabis marketplace and industry, Shango sets the highest standards for product quality and consistency, and business conduct. Shango is committed to cannabis education and is a fierce advocate of the safe and responsible use of cannabis products.
Contact: Richard Gubbe, Shango, 815.670.2620
Virginia Martino, Brand Ltd., 702.257.2345
View original content with multimedia:http://www.prnewswire.com/news-releases/turley-to-appear-on-cnn-special-on-opioid-addiction-treatment-300638213.html
SOURCE Neuro XPF
Latest posts by Bob Allen (see all)
- California voters can now vote postage-free by mail as lawmakers to sign it into law - June 21, 2018
- Ole Miss outfielder Ryan Olenek wins fan voting portion of 2018 C Spire Ferriss Trophy honoring Mississippi's top college baseball player - May 19, 2018
- A Royal Pajama Party in Vegas! The Wedding Capital of the World Went All-In for Harry & Meghan's Big Day as Only Vegas Could - May 19, 2018